HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.32

Change

-0.07 (-0.83)%

Market Cap

N/A

Volume

5.35K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.30 (-1.13%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

-0.47 (-1.38%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.03%)

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

+0.10 (+0.48%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.82 (-2.19%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.75 (-1.65%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.21 (+0.85%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.18 (-1.74%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.32 (-1.42%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.71% 90% A- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.71% 90% A- 77% C+
Trailing 12 Months  
Capital Gain -4.81% 5% F 15% F
Dividend Return 4.69% 77% C+ 66% D+
Total Return -0.12% 7% C- 16% F
Trailing 5 Years  
Capital Gain 0.60% 34% F 41% F
Dividend Return 38.79% 95% A 93% A
Total Return 39.40% 59% D- 55% F
Average Annual (5 Year Horizon)  
Capital Gain 3.63% 54% F 46% F
Dividend Return 4.26% 54% F 42% F
Total Return 0.63% 83% B 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.31% 67% D+ 83% B
Risk Adjusted Return 58.27% 74% C 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike